Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06664788 · ClinicalTrials.gov registry record · NA
A Study of ETHIZIA Versus SURGICEL Original in Controlling Soft Tissue Bleeding During Open Surgery
A NA study of Hemostasis and Hemostatic Techniques, sponsored by Ethicon.
- Recruiting
- Registry status
- NA
- Development phase
- 108
- Enrollment target
- 8
- Study locations
NCT06664788 is a NA study of Hemostasis and Hemostatic Techniques that is actively recruiting participants, run by Ethicon. The registered enrollment target is 108 participants, below the 382-participant average among 7 other Hemostasis trials with a reported enrollment target (72% lower). The trial reports 8 study locations across 7 states.
The verdict
NCT06664788, a NA study of Hemostasis and Hemostatic Techniques, is actively recruiting participants, sponsored by Ethicon.
- RECRUITING
- Registry status
- NA
- Development phase
- 108 participants
- Enrollment target
- 8
- Study locations
Study Summary
The objective of this clinical investigation is to evaluate the safety and efficacy of ETHIZIA to control minimal, mild, or moderate soft tissue bleeding during open surgery when compared to SURGICEL Original in the percentage of cases achieving hemostasis at 3 minutes after product application, and without re-bleeding up to 10 minutes after application.
Conditions Studied
Interventions
- DEVICE ETHIZIA
- DEVICE SURGICEL Original
Study Locations (8)
Other
- UMC Radboud - Nijmegen
- UMC Radboud - Nijmegen
California
- Keck Hospital of USC - Los Angeles
Missouri
- Washington University Barnes Jewish Hospital - St Louis
New Jersey
- Capital Health Medical Center - Hopewell - Pennington
New York
- New York Presbyterian - Weill Cornell Medical Ctr - New York
Texas
- UT Health East Texas EMS Air 1 - Tyler
Utah
- Intermountain Medical Center - Murray
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 108 participants |
| Start Date | 2025-04-16 |
| Est. Completion | 2026-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06664788
The ClinicalTrials.gov registry entry for NCT06664788 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 108 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 382-participant average among 7 other Hemostasis trials with a reported enrollment target (72% lower). The listed sponsor is Ethicon, which has 38 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Hemostasis appearing as the primary indexed condition, and to 2 interventions - of which ETHIZIA is the first listed.
NCT06664788 reports 8 study locations spanning 7 distinct geographic areas - top geographies include Other, California, Missouri.
Frequently Asked Questions
What is clinical trial NCT06664788 about?
NCT06664788 is a clinical study titled "A Study of ETHIZIA Versus SURGICEL Original in Controlling Soft Tissue Bleeding During Open Surgery". The objective of this clinical investigation is to evaluate the safety and efficacy of ETHIZIA to control minimal, mild, or moderate soft tissue bleeding during open surgery when compared to SURGICEL Original in the percentage of cases achieving hemostasis at 3 minutes after product application, and...
What is the current status of trial NCT06664788?
This trial is currently recruiting. It is a NA study. The enrollment target is 108 participants. The study started on 2025-04-16. Estimated completion is 2026-04-30.
What conditions does trial NCT06664788 study?
This clinical trial studies the following conditions: Hemostasis, Hemostatic Techniques.
What interventions are being tested in trial NCT06664788?
The interventions under investigation include: ETHIZIA (DEVICE), SURGICEL Original (DEVICE).
Who is sponsoring clinical trial NCT06664788?
This trial is sponsored by Ethicon, which has 38 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06664788 being conducted?
This trial has 8 study locations across California, Missouri, New Jersey, New York, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hemostasis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Vascular Closure With a Device Compared to Manual Compression After Atrial Fibrillation Ablation: The LockeT II Study
RECRUITING · NA
-
Delivering Transcutaneous Auricular Neurostimulation to Regulate Platelet Activity in Healthy Human Subjects
COMPLETED · NA
-
Randomized Study of Accelerated Radial Arterial Hemostasis
COMPLETED · NA
-
Efficacy and Safety of HemoStyp as an Adjunct for Management of Secondary Hemostasis in the Operative Setting
COMPLETED · NA
-
Investigation of the Genetics of Hematologic Diseases
RECRUITING
-
MANTIS Endoscopic Clipping Study
COMPLETED
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.